ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Coronavirus Disease 2019 (COVID-19)

Monoclonal Antibody Therapy

ASN
Resources
CDC
Links
CMS
Updates
Monoclonal
Antibodies
Other
Orgs
Publications
on COVID-19
Vaccines
Info

Hot Topics: Vaccines Monoclonal Antibodies COVID-19 Toolkit Webinars Podcasts

Webinar: Use of Monoclonal Antibodies for the Treatment of Mild to Moderate SARS-CoV-2 in Patients Receiving Hemodialysis: A Kidney Community Conversation

Recorded: March 11, 2021

Monoclonal antibodies are one of the most recent treatments being considered for administration to dialysis patients in the early stages of COVID-19. Representatives from the CDC, HHS/ASPR, and outpatient dialysis care discuss what is currently known about administering this treatment to people with COVID-19.


Recording | Slides | Speaker Bios


Articles
National Institutes of Health (NIH)
Presentations